+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sepsis Diagnostic Market by Product Type (Instruments, Reagents & Kits, Software & Services), Technology (ELISA, Flow Cytometry, NGS), End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Sepsis Diagnostic Market by Product Type (Instruments, Reagents & Kits, Software & Services), Technology (ELISA, Flow Cytometry, NGS), End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Sepsis Diagnostic Market by Product Type (Instruments, Reagents & Kits, Software & Services), Technology (ELISA, Flow Cytometry, NGS), End User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5311190
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Sepsis Diagnostic Market grew from USD 611.80 million in 2024 to USD 674.24 million in 2025. It is expected to continue growing at a CAGR of 10.02%, reaching USD 1.08 billion by 2030.

Navigating the Urgent Imperative of Sepsis Diagnostics Through Collaborative Innovation and Interdisciplinary Strategies

Sepsis remains one of the most urgent challenges in modern healthcare, claiming lives and exerting unparalleled pressure on clinical infrastructure around the world. As pathogens evolve and patient populations diversify, diagnostic paradigms must adapt to deliver rapid, reliable, and robust tools. This introduction sets the stage for an in-depth exploration of emerging technologies, shifting regulatory pressures, and critical market dynamics. It underscores the need for collaborative research, interdisciplinary innovation, and streamlined pathways to clinical adoption.

By contextualizing the sepsis diagnostics landscape within the broader trends in personalized medicine and value-based care models, decision-makers can navigate complexity with clarity. The subsequent sections will illuminate the transformative shifts reshaping how diagnostics are developed, regulated, and deployed. In doing so, this report empowers stakeholders across industry, academia, and clinical practice to align strategic priorities with the imperatives of patient outcomes, operational efficiency, and sustainable growth.

Accelerating the Future of Sepsis Care by Uniting Digital Biomarkers Artificial Intelligence and Point-of-Care Diagnostics into Unified Clinical Pathways

A profound evolution is underway as digital biomarkers, artificial intelligence-driven analytics, and point-of-care platforms converge to redefine early sepsis detection. Rather than relying solely on traditional laboratory workflows, next-generation diagnostics integrate real-time data streams from wearable sensors, electronic health records, and molecular platforms. This shift accelerates clinical decision cycles, enabling proactive interventions before patients spiral into severe systemic complications.

Simultaneously, regulatory agencies are streamlining approval pathways for companion diagnostics and adaptive algorithms, heralding a new era of precision sepsis management. Healthcare providers are increasingly investing in decentralized testing infrastructures that bridge hospital laboratories and outpatient settings. As these transformative forces intersect, the industry is witnessing a paradigm where speed, specificity, and scalability are no longer mutually exclusive.

Assessing the Ripple Effects of 2025 Tariff Adjustments on Supply Chain Resilience and Cost Structures in Sepsis Diagnostics Industry

The introduction of comprehensive United States tariffs in 2025 has had a ripple effect across every tier of the sepsis diagnostics supply chain. Critical instruments, sophisticated reagents, and genomics-driven kits have faced elevated import duties, compelling manufacturers to reassess global sourcing strategies and consider localized production capabilities. This reshuffling of procurement pathways has introduced complexity, as lead times and cost structures evolved almost overnight.

In response, many stakeholders have accelerated investments in domestic manufacturing facilities, inked strategic partnerships with local suppliers, and diversified their distribution networks. While short-term operational burdens arose as inventory buffers were realigned, the long-term benefits include greater supply-chain resilience and reduced vulnerability to geopolitical fluctuations. These cumulative impacts underscore the importance of agile planning and cross-border collaboration in ensuring uninterrupted access to lifesaving diagnostics.

Holistic Segmentation Perspective Reveals Intricate Overlaps Among Instrumentation Technologies End Users and Distribution Modalities

Diving into product type segmentation reveals that instruments encompass both high-throughput analyzers and portable point-of-care devices engineered for rapid bedside testing. Reagents and kits bifurcate into advanced biomarker kits, harnessing novel protein signatures, and robust culture media designed for traditional microbial growth assays. Software and services deliver strategic value through expert consulting offerings and sophisticated data management platforms that integrate multi-omics and clinical datasets.

When examining the technology dimension, enzyme-linked immunosorbent assays flourish through both competitive formats and sandwich configurations, while flow cytometry spans conventional cell-counting approaches and advanced imaging cytometry. Next-generation sequencing methodologies battle between targeted panels optimized for sepsis-related genes and whole-genome frameworks, alongside polymerase chain reaction variants that range from multiplex assays to real-time quantitative platforms.

End user segmentation demonstrates that ambulatory care centers, split between clinic-based and outpatient-centric models, leverage rapid screening tools for triage. Diagnostic laboratories, comprised of clinical and reference facilities, remain pivotal for confirmatory testing, and hospitals-from general to tertiary care environments-drive adoption of comprehensive diagnostic workflows. Distribution channels include direct engagements with institutional buyers and indirect pathways through distributors and e-commerce solutions.

Uncovering Regional Drivers Shaping Adoption of Cutting-Edge Sepsis Diagnostics Across Americas Europe Middle East Africa and Asia Pacific

Regional dynamics underscore the Americas as a hotbed of technological innovation supported by robust reimbursement frameworks and a dense network of academic-industry research collaborations. Investments in digital health initiatives have propelled pilot programs for bedside diagnostics, enabling rapid proof-of-concept deployments across major health systems.

In the Europe, Middle East & Africa sphere, regulatory harmonization efforts and cross-border clinical trials have fueled the adoption of biomarker-driven strategies. Tiered healthcare infrastructures in emerging markets are catalyzing demand for scalable solutions that balance cost efficiency with diagnostic accuracy.

Meanwhile, the Asia-Pacific arena continues to expand through public-private partnerships and national precision medicine initiatives. Governments are funding capital equipment upgrades and fostering local diagnostic clusters that accelerate clinical validation of next-generation sepsis assays. These regional distinctions inform strategic planning for market entry, distribution partnerships, and tailored product positioning.

Exploring Strategic Alliances Product Innovations and Acquisition Waves Transforming the Competitive Sepsis Diagnostics Market Landscape

Key industry participants are engaging in a dynamic interplay of strategic alliances, product innovation, and targeted acquisitions to strengthen their sepsis diagnostics portfolios. Leading life sciences firms are investing heavily in molecular biomarker discovery, while instrument manufacturers integrate automation and digital connectivity to streamline laboratory operations.

Several organizations are forging collaborations with academic research centers to validate novel diagnostic markers and secure early-stage pipeline assets. Concurrently, specialized diagnostics providers are expanding their footprints through regional partnerships and establishing centers of excellence for sepsis biomarker testing. Across the spectrum, companies are leveraging data analytics platforms to deliver actionable insights, refine performance metrics, and demonstrate clinical utility in real-world environments.

Empowering Leaders to Drive Innovation and Resilience Through Strategic Partnerships Lean Manufacturing and Regulatory Engagement

Industry leaders should prioritize investment in modular point-of-care platforms that can seamlessly integrate new biomarker assays without extensive workflow reconfiguration. Cultivating partnerships with data analytics firms and healthcare providers will accelerate the translation of real-time patient data into decision-support tools that heighten diagnostic precision.

Diversification of manufacturing sites and supplier portfolios is critical to mitigate the effects of future geopolitical shifts or tariff adjustments. Engaging with regulatory bodies early in the development cycle can streamline approval processes for adaptive algorithms and novel assay formats. Furthermore, embedding continuous feedback loops between clinical end users and R&D teams will foster iterative improvements, ultimately enhancing test performance and clinical adoption rates.

Applying Robust Mixed-Method Research Frameworks Coupled with Expert Validation to Illuminate Sepsis Diagnostics Market Realities

This comprehensive analysis is underpinned by a rigorous multi-stage methodology that blends primary and secondary research techniques. Extensive interviews with key opinion leaders, industry executives, and clinical practitioners provided qualitative insights into technology adoption trends and operational pain points.

Secondary data was harvested from peer-reviewed journals, regulatory publications, conference proceedings, and corporate filings to triangulate findings and ensure factual accuracy. Market segmentation frameworks were constructed through iterative data modeling, followed by peer validation from domain experts. All insights have been subjected to strict quality control measures, ensuring that the conclusions drawn accurately reflect the current state of sepsis diagnostics.

Summarizing the Convergence of Technological Prowess Regulatory Evolution and Strategic Collaborations as Pillars of Sepsis Diagnostics Success

As the sepsis diagnostics arena advances, the convergence of digital innovation, regulatory modernization, and strategic collaborations is reshaping how clinicians detect and manage life-threatening infections. Stakeholders who embrace modular platforms, diversified supply chains, and adaptive regulatory strategies will be best positioned to deliver high-impact solutions that reduce mortality rates and enhance patient outcomes.

This report synthesizes the critical shifts across technology, regional, and competitive dimensions to guide informed decision-making. By leveraging the actionable insights contained herein, organizations can optimize their R&D investments, align product roadmaps with clinical demands, and navigate the evolving regulatory terrain with confidence.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Instruments
      • Analyzers
      • Point-Of-Care Devices
    • Reagents & Kits
      • Biomarker Kits
      • Culture Media
    • Software & Services
      • Consulting Services
      • Data Management Software
  • Technology
    • ELISA
      • Competitive ELISA
      • Sandwich ELISA
    • Flow Cytometry
      • Conventional Flow Cytometry
      • Imaging Flow Cytometry
    • NGS
      • Targeted Sequencing
      • Whole Genome Sequencing
    • PCR
      • Multiplex PCR
      • Real-Time PCR
  • End User
    • Ambulatory Care Centers
      • Clinics
      • Outpatient Centers
    • Diagnostic Laboratories
      • Clinical Laboratories
      • Reference Laboratories
    • Hospitals
      • General Hospitals
      • Tertiary Care Hospitals
  • Distribution Channel
    • Direct
    • Indirect
      • Distributors
      • E-Commerce
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Thermo Fisher Scientific Inc.
  • bioMérieux SA
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Siemens Healthineers AG
  • QIAGEN N.V.
  • DiaSorin S.p.A.
  • Bio-Rad Laboratories, Inc.
  • Luminex Corporation

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Implementation of multiplex PCR-based panels enabling rapid pathogen identification in suspected sepsis cases
5.2. Emergence of host-response biomarker assays distinguishing bacterial from viral sepsis to guide antibiotic therapy
5.3. Integration of artificial intelligence algorithms into EHR systems for early sepsis risk stratification and alerting
5.4. Development of microfluidic lab-on-a-chip platforms for bedside sepsis biomarker quantification in emergency settings
5.5. Rising adoption of procalcitonin-guided antibiotic stewardship protocols to reduce overtreatment in sepsis management
5.6. Expansion of telehealth-enabled remote monitoring solutions for post-discharge sepsis patient follow-up and outcome improvement
5.7. Increasing investment in next-generation sequencing methods for comprehensive pathogen surveillance in bloodstream infections
5.8. Collaboration between diagnostics manufacturers and biopharma for companion diagnostic development in sepsis clinical trials
5.9. Standardization of sepsis diagnostic reimbursement pathways to accelerate adoption of innovative testing technologies
5.10. Advancements in CRISPR-based rapid diagnostic assays for precision identification of sepsis-causing pathogens in ICU settings
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Sepsis Diagnostic Market, by Product Type
8.1. Introduction
8.2. Instruments
8.2.1. Analyzers
8.2.2. Point-Of-Care Devices
8.3. Reagents & Kits
8.3.1. Biomarker Kits
8.3.2. Culture Media
8.4. Software & Services
8.4.1. Consulting Services
8.4.2. Data Management Software
9. Sepsis Diagnostic Market, by Technology
9.1. Introduction
9.2. ELISA
9.2.1. Competitive ELISA
9.2.2. Sandwich ELISA
9.3. Flow Cytometry
9.3.1. Conventional Flow Cytometry
9.3.2. Imaging Flow Cytometry
9.4. NGS
9.4.1. Targeted Sequencing
9.4.2. Whole Genome Sequencing
9.5. PCR
9.5.1. Multiplex PCR
9.5.2. Real-Time PCR
10. Sepsis Diagnostic Market, by End User
10.1. Introduction
10.2. Ambulatory Care Centers
10.2.1. Clinics
10.2.2. Outpatient Centers
10.3. Diagnostic Laboratories
10.3.1. Clinical Laboratories
10.3.2. Reference Laboratories
10.4. Hospitals
10.4.1. General Hospitals
10.4.2. Tertiary Care Hospitals
11. Sepsis Diagnostic Market, by Distribution Channel
11.1. Introduction
11.2. Direct
11.3. Indirect
11.3.1. Distributors
11.3.2. E-Commerce
12. Americas Sepsis Diagnostic Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Sepsis Diagnostic Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Sepsis Diagnostic Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Thermo Fisher Scientific Inc.
15.3.2. bioMérieux SA
15.3.3. F. Hoffmann-La Roche Ltd
15.3.4. Abbott Laboratories
15.3.5. Becton, Dickinson and Company
15.3.6. Siemens Healthineers AG
15.3.7. QIAGEN N.V.
15.3.8. DiaSorin S.p.A.
15.3.9. Bio-Rad Laboratories, Inc.
15.3.10. Luminex Corporation
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. SEPSIS DIAGNOSTIC MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. SEPSIS DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. SEPSIS DIAGNOSTIC MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. SEPSIS DIAGNOSTIC MARKET: RESEARCHAI
FIGURE 24. SEPSIS DIAGNOSTIC MARKET: RESEARCHSTATISTICS
FIGURE 25. SEPSIS DIAGNOSTIC MARKET: RESEARCHCONTACTS
FIGURE 26. SEPSIS DIAGNOSTIC MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. SEPSIS DIAGNOSTIC MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY BIOMARKER KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY BIOMARKER KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY CULTURE MEDIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY CULTURE MEDIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY COMPETITIVE ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY COMPETITIVE ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY SANDWICH ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY SANDWICH ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY CONVENTIONAL FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY CONVENTIONAL FLOW CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY IMAGING FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY IMAGING FLOW CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MULTIPLEX PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MULTIPLEX PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY OUTPATIENT CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY OUTPATIENT CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY DIRECT, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY DIRECT, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY E-COMMERCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 171. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 172. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 173. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 174. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 175. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 176. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 177. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 178. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 179. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 180. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 181. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2018-2024 (USD MILLION)
TABLE 182. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2025-2030 (USD MILLION)
TABLE 183. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 184. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 185. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2018-2024 (USD MILLION)
TABLE 186. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2025-2030 (USD MILLION)
TABLE 187. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 188. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 189. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2024 (USD MILLION)
TABLE 192. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2025-2030 (USD MILLION)
TABLE 193. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 194. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 195. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 196. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 197. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2018-2024 (USD MILLION)
TABLE 200. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2025-2030 (USD MILLION)
TABLE 201. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 202. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 203. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 204. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 205. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 206. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 207. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 208. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 209. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 210. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 211. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2018-2024 (USD MILLION)
TABLE 212. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2025-2030 (USD MILLION)
TABLE 213. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 214. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 215. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2018-2024 (USD MILLION)
TABLE 216. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2025-2030 (USD MILLION)
TABLE 217. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 218. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 219. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2024 (USD MILLION)
TABLE 222. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2025-2030 (USD MILLION)
TABLE 223. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 224. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 225. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 226. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 227. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2018-2024 (USD MILLION)
TABLE 230. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2025-2030 (USD MILLION)
TABLE 261. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 262. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 265. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 266. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 267. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 268. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 269. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 270. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 271. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2018-2024 (USD MILLION)
TABLE 272. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2025-2030 (USD MILLION)
TABLE 273. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 274. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 275. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2018-2024 (USD MILLION)
TABLE 276. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2025-2030 (USD MILLION)
TABLE 277. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 278. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 279. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2024 (USD MILLION)
TABLE 282. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2025-2030 (USD MILLION)
TABLE 283. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 284. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 285. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 286. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 287. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 288. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2025-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 301. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2018-2024 (USD MILLION)
TABLE 302. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2025-2030 (USD MILLION)
TABLE 303. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2018-2024 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2025-2030 (USD MILLION)
TABLE 307. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 310. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2024 (USD MILLION)
TABLE 312. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2025-2030 (USD MILLION)
TABLE 313. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 314. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 315. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 316. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 317. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 318. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 319. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2018-2024 (USD MILLION)
TABLE 320. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2025-2030 (USD MILLION)
TABLE 321. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 322. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 323. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 324. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 325. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 326. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 327. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 328. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 329. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 330. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 331. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 332. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 333. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2018-2024 (USD MILLION)
TABLE 334. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2025-2030 (USD MILLION)
TABLE 335. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 336. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 337. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2018-2024 (USD MILLION)
TABLE 338. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2025-2030 (USD MILLION)
TABLE 339. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 340. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 341. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 342. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 343. UNITED KINGDOM SEPS

Samples

Loading
LOADING...

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • bioMérieux SA
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Siemens Healthineers AG
  • QIAGEN N.V.
  • DiaSorin S.p.A.
  • Bio-Rad Laboratories, Inc.
  • Luminex Corporation

Table Information

Report AttributeDetails
No. of Pages198
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 674.24 Million
Forecasted Market Value ( USD ) by 2030 $ 1080 Million
Compound Annual Growth Rate10.0%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Sepsis Diagnostics Market Size, Share & Trends Analysis Report By Product (Assay Kits & Reagents, Blood Culture Media), By Technology (Microbiology, Immunoassays), By Pathogen, By Testing, By Method, By End-usse, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Sepsis Diagnostics Market Size, Share & Trends Analysis Report By Product (Assay Kits & Reagents, Blood Culture Media), By Technology (Microbiology, Immunoassays), By Pathogen, By Testing, By Method, By End-usse, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Sepsis Diagnostics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Sepsis Diagnostics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 84 Pages
  • Global
From
Sepsis Diagnostics - Global Strategic Business Report - Product Image

Sepsis Diagnostics - Global Strategic Business Report

  • Report
  • 173 Pages
  • Global
From
Sepsis Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Sepsis Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Sepsis Diagnostics Market Outlook Report: Industry Size, Market Shares Data, Latest Trends, Insights, Growth Potential, CAGR Forecasts to 2034 - Product Image

Sepsis Diagnostics Market Outlook Report: Industry Size, Market Shares Data, Latest Trends, Insights, Growth Potential, CAGR Forecasts to 2034

  • Report
  • 150 Pages
  • Global
From

About the Sepsis Test Market

The Sepsis Test market is a subset of the Diagnostics industry, focused on the detection and diagnosis of sepsis. Sepsis is a life-threatening condition caused by the body's response to an infection, and early diagnosis is critical for successful treatment. Sepsis tests are used to detect the presence of sepsis-causing bacteria in the blood, and to identify the type of bacteria present. Tests may also be used to monitor the progress of treatment. Sepsis tests are typically performed in a laboratory setting, and may include blood cultures, urine cultures, and other tests. Tests may also be performed using point-of-care devices, which allow for rapid diagnosis in the clinical setting. Companies in the Sepsis Test market include Abbott, Becton Dickinson, bioMérieux, Cepheid, DiaSorin, and Roche. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.